Cargando…
Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
BACKGROUND: Appropriate assessment is essential for the management of chemotherapy-induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated, which is high on the list of causes of distress for cancer patients. However, objective assessment by medical staff makes it e...
Autores principales: | Kanda, K., Fujimoto, K., Mochizuki, R., Ishida, K., Lee, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734590/ https://www.ncbi.nlm.nih.gov/pubmed/31506070 http://dx.doi.org/10.1186/s12885-019-6113-3 |
Ejemplares similares
-
Emotional Responses to Persistent Chemotherapy-induced Peripheral Neuropathy Experienced by Patients with Colorectal Cancer in Japan
por: Kanda, Kiyoko, et al.
Publicado: (2017) -
Chemotherapy‐induced peripheral neuropathy increases nontraumatic fracture risk in breast cancer survivors
por: McNeish, Brendan L., et al.
Publicado: (2021) -
Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes
por: Trendowski, Matthew R., et al.
Publicado: (2021) -
Randomized clinical trial quantifying the effectiveness of a self-monitoring intervention in cancer patients with peripheral neuropathy: A quantitative study
por: Kanda, Kiyoko, et al.
Publicado: (2023) -
Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
por: Argyriou, Andreas A, et al.
Publicado: (2014)